SOS
ABBV icon

Silver Oak Securities’s AbbVie ABBV Stock Holding History

Silver Oak Securities’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.55M Sell
11,725
-1,640
-12% -$364K 0.19% 121
2025
Q4 		$3.07M Buy
13,365
+1,405
+12% +$320K 0.21% 109
2025
Q3 		$2.77M Buy
11,960
+5,777
+93% +$1.18M 0.21% 111
2025
Q2 		$1.15M Sell
6,183
-1
-0% -$186 0.09% 229
2025
Q1 		$1.27M Buy
6,184
+69
+1% +$13.4K 0.12% 190
2024
Q4 		$1.08M Buy
6,115
+2,128
+53% +$391K 0.1% 215
2024
Q3 		$777K Buy
3,987
+521
+15% +$97.2K 0.08% 252
2024
Q2 		$595K Sell
3,466
-372
-10% -$61.6K 0.09% 196
2024
Q1 		$699K Buy
3,838
+505
+15% +$87K 0.11% 184
2023
Q4 		$517K Sell
3,333
-1,011
-23% -$147K 0.07% 267
2023
Q3 		$648K Sell
4,344
-2,664
-38% -$391K 0.14% 141
2023
Q2 		$944K Buy
7,008
+433
+7% +$63.5K 0.15% 141
2023
Q1 		$1.05M Sell
6,575
-671
-9% -$103K 0.17% 107
2022
Q4 		$1.17M Buy
7,246
+2,902
+67% +$445K 0.22% 83
2022
Q3 		$648K Sell
4,344
-2,525
-37% -$362K 0.14% 141
2022
Q2 		$1.02M Buy
6,869
+409
+6% +$62.5K 0.23% 78
2022
Q1 		$1.13M Buy
+6,460
New +$938K 0.23% 102

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Silver Oak Securities's ABBV Position: Q1 2026 in Review

Silver Oak Securities reduced its AbbVie (ABBV) stake by 12% in Q1 2026, selling an estimated $364K and leaving 11,725 shares worth $2.55M. The position accounts for 0.19% of the portfolio, ranked #121.

Silver Oak Securities first reported a position in ABBV in Q1 2022 and has held it in 17 quarters since. The position peaked at $3.07M in Q4 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Silver Oak Securities held 11,725 shares of AbbVie worth $2.55M as of Q1 2026.
  • Silver Oak Securities sold 1,640 AbbVie shares in Q1 2026, an estimated $364K.
  • AbbVie made up 0.19% of Silver Oak Securities's portfolio in Q1 2026, its #121 holding.
  • Silver Oak Securities first reported a position in AbbVie in Q1 2022 and has held it in 17 quarters since.
  • Silver Oak Securities's AbbVie position peaked at $3.07M in Q4 2025.
  • 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Silver Oak Securities's 13F filing for Q1 2026, filed 20 Apr 2026.